SXTC
China SXT Pharmaceuticals, Inc. (NASDAQ)
Healthcare — Drug Manufacturers - Specialty & Generic
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Price History
Fundamentals
| Market Cap | $11.15M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-57.15 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | -24.50% |
| ROE | -50.30% |
| Debt/Equity | 5.95 |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 63.7 |
| Beta | 1.89 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $1047.00 |
| 52-Week Low | $1.25 |
| 50-Day Avg | $1.92 |
| 200-Day Avg | $93.87 |
| Avg Volume | 67.3K |
| Volume | $25.59M |
Performance Analysis
NEUTRALSXTC presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:33 UTC
Back to Screener Export Report